The influence of dietary isoflavone on the uterotrophic response in juvenile rats.
Current in vivo methods to identify and assess reproductive hazards of endocrine disrupting substances are often confounded by the presence of isoflavones (genistein, diadzein, glycitein), strongly hormonally-active substances, in the diet of laboratory rodents. However, studies that have attempted to study the influence of dietary isoflavone on qualitative and quantitative uterotrophic responses have been limited by the few doses of isoflavone tested, stress to the animals due to changing of the diet immediately prior to testing and/or comparing effects of diets of very different composition. The current study examined the effects of isoflavone on uterotrophic response by using immature female rats reared from conception on diets varying only in the amount of isoflavone concentrate (Novasoy) added to a virtually isoflavone-free soya-based diet. The effects of these diets, and a soya-free semipurified diet (AIN 93G) on uterotrophic responses to treatment with a strong (Ethinyl Estradiol, EE) or a weak (bisphenol A, BPA) estrogenic substance were examined. The pups were treated with subcutaneous injections of either EE (1 microg/kg/day), BPA (600 mg/kg/day) or corn oil (vehicle) control for 3 days starting at weaning on post natal day (PND) 21. On the morning of PND 24 pups were sacrificed and uterus weight, epithelium labeling index (Bromo deoxyuridine incorporation), uterine epithelium thickness, and peroxidase activity were determined. Diet did not influence unstimulated uterine weight, epithelial height or peroxidase activity except at the highest isoflavone diet where animals had significantly increases in all three endpoints. Uterine weight, epithelial thickness and peroxidase were all significantly increased by EE or BPA treatment. There was no evidence of diet-induced potentiation or inhibition of the stimulatory actions of either EE or BPA on either uterine weight or epithelial thickness while EE-induced increase in uterine peroxidase activity was increased synergistically by the highest dose of isoflavone. A similar response to the latter effect was seen in BPA treated animals although this response was not significantly different from that of BPA treated rats fed the isoflavone-free soy diet. The rate of endometrial epithelium labeling with BrdU was not altered by any treatment. These results indicate that dietary isoflavone content can directly influence uterine weight and other estrogen-dependent endpoints demonstrating the potential of these to reduce the active range of the uterotrophic assay. However, there is no indication that isoflavones impair or potentiate the stimulatory action of either strong (EE) or weaker (BPA) estrogen agonists on uterine weight or epithelial morphology although the data do suggest the potential for synergy between high isoflavone content and estrogen agonist in inducing uterine peroxidase.
Wade
Michael G
MG
Environmental & Occupational Toxicology Division, Healthy Environments & Consumer Safety Branch, Room 315, Environmental Health Centre, PL 0803D, Tunney's Pasture, Ottawa, Ontario, Canada K1A 0L2. mike_wade@hc.sc.gc.ca
Lee
Alice
A
McMahon
Avril
A
Cooke
Gerard
G
Curran
Ivan
I
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001559:Benzhydryl Compounds; D001724:Birth Weight / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001973:Bromodeoxyuridine / Q000494:pharmacology; D004032:Diet; D045166:Estradiol Congeners / Q000494:pharmacology; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000473:pathology; D007529:Isoflavones / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D016612:Paraffin Embedding; D010544:Peroxidases / Q000378:metabolism; D010636:Phenols / Q000494:pharmacology; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology; D051381:Rats; D013025:Glycine max / Q000737:chemistry; D014599:Uterus / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D000098826:Bisphenol A Compounds
D000963:Antimetabolites; D001559:Benzhydryl Compounds; D001973:Bromodeoxyuridine; D045166:Estradiol Congeners; D004968:Estrogens, Non-Steroidal; D004997:Ethinyl Estradiol; D007529:Isoflavones; D010544:Peroxidases; D010636:Phenols; D010936:Plant Extracts; C006780:bisphenol A; D000098826:Bisphenol A Compounds